SEC Form 3 · accession 0001144204-15-019026
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Michael Jones
Officer — COO
Period of report
Mar 11, 2015
Accepted (ET)
Mar 27, 2015 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | holding | — | — | — | 2,544 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Purchase OptionF1 | $3.80 | holding | — | — | — | — | Apr 25, 2015 | Common Stock | 2,484 | — | D |
| Stock Purchase OptionF2 | $3.81 | holding | — | — | — | — | Feb 22, 2016 | Common Stock | 1,076 | — | D |
| Stock Purchase OptionF3 | $5.20 | holding | — | — | — | — | Oct 2, 2017 | Common Stock | 11,838 | — | D |
| Stock Purchase OptionF4 | $2.46 | holding | — | — | — | — | Jan 21, 2019 | Common Stock | 4,969 | — | D |
| Stock Purchase OptionF5 | $1.38 | holding | — | — | — | — | May 6, 2020 | Common Stock | 10,000 | — | D |
| Stock Purchase OptionF6 | $3.55 | holding | — | — | — | — | Dec 8, 2020 | Common Stock | 3,797 | — | D |
| Stock Purchase OptionF7 | $3.55 | holding | — | — | — | — | Dec 8, 2020 | Common Stock | 1,266 | — | D |
| Stock Purchase OptionF8 | $1.76 | holding | — | — | — | — | Sep 30, 2021 | Common Stock | 20,000 | — | D |
| Stock Purchase OptionF9 | $1.21 | holding | — | — | — | — | Dec 1, 2021 | Common Stock | 5,625 | — | D |
| Stock Purchase OptionF10 | $1.21 | holding | — | — | — | — | Dec 1, 2021 | Common Stock | 3,830 | — | D |
| Stock Purchase OptionF11 | $1.13 | holding | — | — | — | — | Dec 3, 2022 | Common Stock | 5,063 | — | D |
| Stock Purchase OptionF12 | $1.94 | holding | — | — | — | — | Jan 29, 2024 | Common Stock | 6,188 | — | D |
| Stock Purchase OptionF13 | $1.83 | holding | — | — | — | — | Mar 27, 2024 | Common Stock | 15,000 | — | D |
| Stock Purchase OptionF14 | $1.71 | holding | — | — | — | — | Dec 8, 2024 | Common Stock | 30,000 | — | D |
Explanation of responses
- F1These options became exercisable in 4 equal annual installments, with the first installment exercisable on April 25, 2006.
- F10These options became exercisable on December 1, 2012.
- F11These options are exercisable in 4 equal annual installments, with the first installment exercisable on December 3, 2012.
- F12These options are exercisable in 4 equal annual installments, with the first installment exercisable on January 29, 2014.
- F13These options are exercisable in 4 equal annual installments, with the first installment exercisable on March 27, 2015.
- F14These options are exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014.
- F2These options became exercisable as follows: 25% on February 22, 2006, and the remaining 75% in 36 equal monthly installments, beginning March 22, 2006.
- F3These options became exercisable as follows: 20% on October 2, 2007, 20% on October 2, 2008 and the remainder in 36 equal monthly installments, beginning November 2, 2008.
- F4These options became exercisable in 4 equal annual installments, with the first installment exercisable on January 21, 2010.
- F5These options became exercisable in 4 equal annual installments, with the first installment exercisable on May 6, 2011.
- F6These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2011.
- F7These options became exercisable on December 8, 2010.
- F8These options became exercisable on September 30, 2012.
- F9These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 1, 2011.